Future Diagnostics intends to become the leading developer of diagnostic tests for third parties. Their vision is to be the market leader in test development and the preferred partner of the top 25 in vitro diagnostic companies. They aim to achieve this through rapidly developing innovative tests using new technologies and intellectual properties. Future Diagnostics was founded in 1997 and currently has 65 employees working on 35 projects. They have developed over 120 assays covering areas like cancer, infectious disease, and autoimmune disorders. They have experience developing tests on many platforms and using technologies like chemiluminescence. Their goal is to make their laboratory a collaborative partner for clients by balancing costs through a mixed business model of monthly fees and royalties on sales.